09:00
#100 BOTULINUM TOXIN A 100 vs 150 UNITS IN IDIOPATHIC OVERACTIVE BLADDER PATIENTS: IS THERE ANY DIFFERENCE?
Gousse A1, Cohen B1, Rodriguez D1, Barboglio P11. University of Miami Miller School of Medicine
09:07
#101 Refractory Urge Urinary Incontinence and Botulinum A toxin Injection Trial
Brubaker L1, & Pelvic Floor Disorders Network .11. Loyola University, Chicago
09:15
#102 BOTULINUM TOXIN A: INTRADETRUSOR RE-INJECTIONS IN IDIOPATHIC OVERACTIVE BLADDER EVERY 6 MONTHS - 3 YEARS FOLLOW UP
09:22
#103 REPEATED INTRADETRUSOR INJECTIONS OF BOTOLINUM TOXIN-A IN NEUROGENIC OVERACTIVE BLADDER: URODYNAMIC, UDI-6 AND QUALITY OF LIFE DATA
Gousse A1, Rivera R1, Tunuguntla H1, Barboglio P11. University of Miami Miller School of Medicine
09:30
#104 Long-term follow-up of refractory neurogenic detrusor overactivity patients with English botulinum toxin A: one single centre experience
Del Popolo G1, Filocamo M T2, Li Marzi V2, Macchiarella A1, Lombardi G1, Nicita G21. Neuro-Urology, Florence - Italy, 2. Clinica Urologica II, University of Florence - Italy
09:37
#105 Trigonal injection of botulinum toxin type A does not cause vesicoureteral reflux in patients with refractory neurogenic detrusor overactivity
Gomes C1, Mascarenhas F2, Cocuzza M11. Division of Urology, University of Sao Paulo School of Medicine, 2. Sarah Kubitschek Hospital, Salvador, BA, Brazil
09:45
#106 Botulinum toxin into the trigone in neurogenic overactive bladder non responder to detrusor injection
spinelli M1, citeri M1, zanollo L1, macrellino E1, redaelli T11. neurourology - niguarda hospital
09:52
#107 A RANDOMIZED CONTROLLED TRIAL OF BACILLUS CALMETTE-GUERIN AND BOTULINUM TOXIN-A FOR THE TREATMENT OF REFRACTORY INERSTITIAL CYSTITIS
TAHA M1, FARAHAT Y1, BAHNASY A1, DAMHOUGY M21. EGYPT, TANTA FACULTY OF MEDICINE, 2. Mebarrah Insurance Hospital Tanta